Recall alert: Benzene prompts nationwide recall of select Banana Boat Hair & Scalp sunscreen

SHETLON, Ct. — Edgewell Personal Care Co. on Friday issued a voluntary nationwide recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30 after an internal review found that some samples contained trace levels of benzene.

>> Read more trending news

Although benzene is not an ingredient in any Banana Boat products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can, according to the recall notice, published in concert with the U.S. Food and Drug Administration.

The affected batches are as follows:

UPCDescriptionLot CodeExpirationSixe
0-79656-04041-8Banana Boat Hair & Scalp Spray SPF 3020016AFDecember 20226-ounce
0-79656-04041-8Banana Boat Hair & Scalp Spray SPF 3020084BFFebruary 20236-ounce
0-79656-04041-8Banana Boat Hair & Scalp Spray SPF 3021139AFApril 20246-ounce

According to Edgewell officials, no other batches or products are affected, and no adverse events related to the recall have been reported.

Benzene, classified as a human carcinogen, can be inhaled or absorbed through the skin, and substantial exposure can result in leukemia and blood cancer of the bone marrow, along with blood disorders, according to the FDA.

Per the recall, the affected products, which were sold nationwide both online and in brick-and-mortar stores, are packaged in aerosol cans. Edgewell has notified its retailers to remove any remaining recalled product from shelves.

Banana Boat will also offer reimbursement for consumers who have purchased a product marked with one of the lot codes in the table above. Lot codes are located on the bottom of the can.

Consumers are advised to stop using the affected product immediately and to discard them appropriately. Consumers with questions may contact Edgewell at 888-686-3988 Monday through Friday between 9 a.m. and 6 p.m. EDT, or online at www.bananaboat.com.

Meanwhile, adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.